Table 2. Metabolic disorder occurred in enrolled pregnant women during follow up.
| Variables | Total | BMI <24 | BMI ≥24 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| H. pylori infection | No H. pylori infection | P value | H. pylori infection | No H. pylori infection | P value | H. pylori infection | No H. pylori infection | P value | |||
| Number | 78 | 242 | 52 | 159 | 26 | 83 | |||||
| Age | 27.4±3.7 | 27.1±4.1 | 0.526 | 27.3±3.7 | 26.7±4.2 | 0.392 | 27.6±3.9 | 27.6±4.0 | 0.924 | ||
| BMI | 22.9±5.1 | 22.6±4.6 | 0.619 | 20.9±2.3 | 20.8±2.7 | 0.902 | 27.9±3.5 | 26.9±2.6 | 0.101 | ||
| History of smoking | 6 (7.7%) | 8 (3.3%) | 0.100 | 6 (11.5%) | 7 (4.4%) | 0.063 | 0 (0%) | 1 (1.2%) | 0.574 | ||
| Reproductive history | 0.674 | ||||||||||
| Primipara | 54 (69.2%) | 178 (73.6%) | 0.457 | 34 (65.4%) | 115 (72.3%) | 0.340 | 19 (73.1%) | 64 (77.1%) | |||
| Multipara | 24 (30.8%) | 64 (26.4%) | 18 (34.6%) | 44 (27.7%) | 7 (26.9%) | 19 (22.9%) | |||||
| Elevated BP | 14 (17.9%) | 17 (7.0%) | 0.005 | 5 (9.6%) | 6 (3.8%) | 0.100 | 9 (34.6%) | 11 (13.3%) | 0.014 | ||
| Elevated BG | 15 (19.2%) | 22 (9.1%) | 0.015 | 4 (7.7%) | 10 (6.3%) | 0.724 | 11 (42.3%) | 12 (14.5%) | 0.002 | ||
| Elevated TG | 14 (17.9%) | 21 (8.7%) | 0.023 | 3 (5.8%) | 8 (5.0%) | 0.835 | 11 (42.3%) | 13 (15.7%) | 0.004 | ||
| Elevated HDL-c | 13 (16.7%) | 12 (5.0%) | 0.001 | 3 (5.8%) | 2 (1.3%) | 0.063 | 10 (38.5%) | 10 (12.0%) | 0.002 | ||
| MetS | 18 (23.1%) | 22 (9.1%) | 0.001 | 3 (5.8%) | 4 (2.5%) | 0.255 | 15 (57.7%) | 18 (21.7%) | <0.001 | ||
BMI, body mass index; WC, waist circumference; BP, blood pressure; BG, blood glucose; TG, triglycerides; HDL-c, high-density lipoprotein cholesterol; MetS, metabolic syndrome.